InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,610.00
(
0.00%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.20
(
-0.33%
)
Bitcoin
63,787.90
(
0.98%
)
Post# of 514
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Roland Rick Perry

Send PM Follow Ignore
Followers 15
Posts 571
Boards Moderated 1
Alias Born 08/04/2011

Roland Rick Perry

Re: None

Tuesday, 09/20/2016 1:01:27 PM

Tuesday, September 20, 2016 1:01:27 PM

Post# of 514
IMMU Report uploaded.

Epic Short Squeeze Inflection Point Nears, as Company Moves Further into the Clinical Trial Process.

“Patients and doctors have been waiting for these targeted therapies against TNBC. Now the first ones are in the clinic. I can’t tell you how exciting this is. These drugs or ones very much like them could be game-changers for triple-negative breast cancer.” Jennifer Diamond, MD University of Colorado Cancer Center.

http://biotechstockreview.ning.com/profiles/blogs/immunomedics-3-00-epic-short-squeeze-inflection-point-nears
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up